Table 2.
Median and range of neonatal concentrations of inflammatory markers among patients with B-cell precursor ALL and controls
| Detection Range pg/mL | B-cell precursor ALL patients (n = 178) |
Controls (n = 178) |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Mediana pg/mL | Range pg/mL | Below level of detection n (%) | Missing n (%) | Mediana pg/mL | Range pg/mL | Below level of detection n (%) | Missing n (%) | ||
| IL6 | 0.97–5,000 | 0.99 | 0.06–7.79 | 81 (45.5) | 12 (6.7) | 0.78 | 0.001–7.51 | 108 (60.7) | 12 (6.7) |
| sIL6Rα | 29.01–200,000 | 2,307.09 | 725.49–7,091.02 | 0 (0) | 0 (0) | 2,617.23 | 999.78–7,115.50 | 0 (0) | 0 (0) |
| IL8 | 0.46–5,000 | 1.66 | 0.68–506.68 | 0 (0) | 0 (0) | 1.92 | 0.51–6.29 | 0 (0) | 0 (0) |
| IL12 | 4.08–5,000 | 10.27 | 4.34–24.48 | 0 (0) | 0 (0) | 10.47 | 1.57–75.07 | 4 (2.2) | 0 (0) |
| IL17 | 3.79–5,000 | 4.99 | 0.31–14.85 | 55 (30.9) | 16 (9.0) | 4.55 | 0.19–12.83 | 64 (36.0) | 19 (10.7) |
| IL18 | 0.28–5,000 | 14.61 | 4.21–45.65 | 0 (0) | 0 (0) | 13.41 | 2.42–49.57 | 0 (0) | 0 (0) |
| TGFβ1 | 3.12–40,000 | 87.87 | 34.17–211.16 | 0 (0) | 0 (0) | 102.61 | 28.61–288.59 | 0 (0) | 0 (0) |
| MCP-1 | 4.28–50,000 | 123.06 | 45.94–282.56 | 0 (0) | 0 (0) | 154.61 | 68.22–339.36 | 0 (0) | 0 (0) |
| CRP (μg/mL) | <0.001–10 | 0.17 | 0.0034–1.27 | 0 (0) | 0 (0) | 0.24 | 0.012–1.89 | 0 (0) | 0 (0) |
a
Before changing missing values to a value corresponding to the lowest percentile.